(514) 393-1055

Chemical Computing Group Opens Office in Cambridge, UK

MONTREAL and CAMBRIDGE, UK, March 26, 2002

Chemical Computing Group AG. (CCG) is expanding by opening an office in Cambridge, UK, in order to strengthenits presence in Europe and serve its fast-growing existing customer basethere. The office is located at St. Johns Innovation Centre, at the northend of Cambridge, which is seen as an ideal location due to the largecluster of technology-based companies, including biotech andpharmaceuticals, in the region. This effectively doubles CCG's Europeanoperations, supplementing the existing office at Lorrach, Germany. TheCambridge office will service customers in the UK, Ireland, Benelux andScandanavia.

Dr Stephen J. Maginn, recently Manager of Support and Marketing at the Cambridge Crystallographic Data Centre (CCDC), has joined CCG to set up and run the new office. "This is a great opportunity both for CCG and for me personally," said Dr Maginn. "CCG with its MOE software, and the way in which they interact with their customers, has set new standards in the industry, and I am very much looking forward to helping to extend this to Northern Europe by establishing a firm presence here for the company."

Bill Hayden, CCG's Vice President of Sales and Marketing, is equally enthusiastic. "We see great possibilities for growth in Europe," he said. "We have made a great start with our office in Germany, manned by Dr Wolfram Altenhofen. With the addition of Dr. Maginn in the UK, we will be able to exploit those possibilities and expand our presence further. In the near future, we foresee CCG providing customer support locally within Europe, so there is plenty of room for expansion."

Chemical Computing Group (http://www.chemcomp.com) develops and markets MOE, the Molecular Operating Environment, a leading application for chemical researchers in the pharmaceutical and biotechnology fields. Its built-in applications cover the spectrum of drug discovery including: Protein/Homology modeling, High Throughput Screening, Combinatorial Library Design, Modeling/Simulations and Methods Development. MOEs unique architecture and platform independence allows it to be used corporate-wide by a variety of researchers - from methods developers to computational experts to medicinal chemists. Its customers include a worldwide roster of leading pharmaceutical and biotechnology companies.

For further information, contact Dr Steve Maginn, Chemical Computing Group, St Johns Innovation Centre, Cowley Road, Cambridge CB4 0WS, UK; phone +44 (0)1440 760953; e-mail .

Dr Steve Maginn obtained a PhD from the University of Liverpool in 1989, having studied a crystallographic technique for the determination of molecular structure in challenging cases using synchrotron radiation. He has since worked at ICI Chemicals and Polymers, Molecular Simulations Inc. (now Accelrys), the UK Daresbury Laboratory, and most recently at the Cambridge Crystallographic Data Centre - posts which have given him a unique insight into the applications of crystallographic knowledge in a wide range of industrial and commercial settings. He was for a time Treasurer of the British Crystallographic Association, and is currently a member of the Royal Society of Chemistry's Molecular Modelling Group committee.